PsychedeLinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Decriminalization, Legalization, & Other State Efforts
New York Lawmakers File Amended Psychedelics Legalization Bill, With New Regulations And Protections
A bill to legalize psychedelics in New York has been significantly revised, with new provisions to allow for the possession, gifting and sanctioned use of natural plants and fungi in ceremonial and therapeutic settings for adults 21 and older. The amended legislation from Assemblymember Linda Rosent…
Oregon Psilocybin Services Act
A Central Oregon County-by-County Breakdown as Psilocybin Back on Ballot
A magic mushroom measure passed two years ago still has another hill to climb at the ballot box. Oregon’s approval of Measure 109 in 2020 allowed for psilocybin production and therapies in the stat
5 Cities in Lane County Might Ban Psilocybin-Related Businesses Allowed Under M109
Voters in Cottage Grove, Creswell, Dunes City and Junction City will cast ballots on a full ban. Coburg voters will decide on a potential two-year ban
Science, Therapy, & Research
Can Psilocybin Challenge Our Pharmaceutical Dependence?
The collective attitude about psilocybin mushrooms has shifted dramatically. Here’s why the psychedelic substance is becoming a breakthrough treatment for mental health.
Compass Pathways Will Lead Two Concurrent Phase 3 Trials on Psilocybin-Assisted Therapy for Depression
Psychedelics biotech company Compass Pathways (NASDAQ: CMPS) announced it will conduct two separate Phase 3 clinical trials to study psilocybin-assisted therapy on Treatment-Resistant Depression (TRD),
New Group Focused on Standardizing Psychedelic Therapy Practices
The American Psychedelic Practitioners Association, a new group founded to foster professionalism and standards of care in psychedelic therapy, is welcoming new members at a conference in New York.
Business
Palo Santo Raises $50 MLN for Largest-Ever Venture Capital Fund Focused Purely on Psychedelic Medicine
Venture capital fund Palo Santo is closing its oversubscribed debut fund with $50 million of commitments in what the two-year-old firm describes as the...
Field Trip Announces Relaunch and Refresh of Its Award-Winning Psychedelic App
The app, now called Field Trip, includes new features, new content, and is part of the Company’s new community-focused, digital-centric growth strategyTORONTO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) (“Field Trip” or the “Company”), the global leader in the…
Subscribe
Subscribe to PsychedeLinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
